Company’s eighth patent adds to robust IP Portfolio further establishing the unique efficacy of Fortetropin® in combating muscle loss CEDAR KNOLLS, N.J., Dec. 12, 2023 /PRNewswire-PRWeb/ — MYOS CORP, an innovation-driven medical nutrition company, announced today that it has been awarded…
MYOS CORP Announces Significant New Patent for Increasing Mobility and Activity in Dogs
This post was originally published on this site